Purpose: To compare early and late toxicities, dosimetric parameters and quality of life (QoL) between conventionally fractionated proton beam therapy (PBT) and intensity-modulated radiation therapy (IMRT) in prostate cancer (PCA) patients. Methods: Eighty-eight patients with localized PCA treated between 2013 and 2017 with either definitive PBT (31) or IMRT (57) were matched using propensity score matching on PCA risk group, transurethral resection of the prostate, prostate volume, diabetes mellitus and administration of anticoagulants resulting in 29 matched pairs. Early and late genitourinary (GU) and gastrointestinal (GI) toxicities according to Common Terminology Criteria for Adverse Events (CTCAE) and QoL based on EORTC-QLQ-C30/PR25 q...
PurposeTo report clinical outcomes in patients treated with image guided proton therapy (PT) for loc...
Purpose: To investigate the role of IMRT in reducing the risk of acute genito-urinary (GU), upper ga...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106701/1/cncr28536.pd
Purpose: Although proton beam therapy (PBT) is a rapidly expanding modality to treat prostate cancer...
Background Despite increasing utilization of proton-beam therapy (PBT) in the postprostatectomy sett...
BACKGROUND: Recent studies have suggested differing toxicity patterns for patients with prostate ca...
<p><b>Purpose:</b> To report acute and late genitourinary (GU) and gastrointestinal (GI) toxicities ...
Purpose: Technical developments in the field of external beam radiation therapy (RT) enabled the cli...
Yasushi Nakai,1 Nobumichi Tanaka,1 Satoshi Anai,1 Makito Miyake,1 Isao Asakawa,2 Yosuke Morizawa,1 S...
Background and purpose: For irradiation of localized prostate-cancer, moderately-hypofractionated re...
Purpose: Quality of life (QoL) outcomes play a major role in the treatment selection for prostate ca...
Purpose: We examined a prospective consecutive cohort of low dose rate (LDR) brachytherapy for prost...
Introduction: In prostate cancer, higher radiation doses are often related to higher local control r...
Objective: No previous studies have reported the longitudinal health-related quality of life (HRQOL)...
PURPOSE: High-dose-rate brachytherapy (HDR-BT) with external beam radiation therapy (EBRT) is a comm...
PurposeTo report clinical outcomes in patients treated with image guided proton therapy (PT) for loc...
Purpose: To investigate the role of IMRT in reducing the risk of acute genito-urinary (GU), upper ga...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106701/1/cncr28536.pd
Purpose: Although proton beam therapy (PBT) is a rapidly expanding modality to treat prostate cancer...
Background Despite increasing utilization of proton-beam therapy (PBT) in the postprostatectomy sett...
BACKGROUND: Recent studies have suggested differing toxicity patterns for patients with prostate ca...
<p><b>Purpose:</b> To report acute and late genitourinary (GU) and gastrointestinal (GI) toxicities ...
Purpose: Technical developments in the field of external beam radiation therapy (RT) enabled the cli...
Yasushi Nakai,1 Nobumichi Tanaka,1 Satoshi Anai,1 Makito Miyake,1 Isao Asakawa,2 Yosuke Morizawa,1 S...
Background and purpose: For irradiation of localized prostate-cancer, moderately-hypofractionated re...
Purpose: Quality of life (QoL) outcomes play a major role in the treatment selection for prostate ca...
Purpose: We examined a prospective consecutive cohort of low dose rate (LDR) brachytherapy for prost...
Introduction: In prostate cancer, higher radiation doses are often related to higher local control r...
Objective: No previous studies have reported the longitudinal health-related quality of life (HRQOL)...
PURPOSE: High-dose-rate brachytherapy (HDR-BT) with external beam radiation therapy (EBRT) is a comm...
PurposeTo report clinical outcomes in patients treated with image guided proton therapy (PT) for loc...
Purpose: To investigate the role of IMRT in reducing the risk of acute genito-urinary (GU), upper ga...
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/106701/1/cncr28536.pd